A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution

Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleu...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 43; no. 8; p. 114587
Main Authors Zhang, Yichi, Dos Santos, Matthieu, Huang, Huocong, Chen, Kenian, Iyengar, Puneeth, Infante, Rodney, Polanco, Patricio M., Brekken, Rolf A., Cai, Chunyu, Caijgas, Ambar, Cano Hernandez, Karla, Xu, Lin, Bassel-Duby, Rhonda, Liu, Ning, Olson, Eric N.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 27.08.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleus multi-omics on skeletal muscles from a mouse model of cancer cachexia and profiled the molecular changes in cachexic muscle. Our results revealed the activation of a denervation-dependent gene program that upregulates the transcription factor myogenin. Further studies showed that a myogenin-myostatin pathway promotes muscle atrophy in response to cancer cachexia. Short hairpin RNA inhibition of myogenin or inhibition of myostatin through overexpression of its endogenous inhibitor follistatin prevented cancer cachexia-induced muscle atrophy in mice. Our findings uncover a molecular basis of muscle atrophy associated with cancer cachexia and highlight potential therapeutic targets for this disorder. [Display omitted] •KIC is a pancreatic cancer model manifesting severe cancer cachexia-induced muscle atrophy•Multi-omics analysis reveals activation of denervation-responsive and catabolic genes in KIC muscle•Inhibition of the myogenin-myostatin axis rescues muscle atrophy in KIC mice In this study, Zhang et al. show that denervation-responsive and catabolic genes are induced in cachexic muscle from a genetic mouse model of pancreatic cancer. The activation of a myogenin-myostatin axis drives muscle atrophy in this model, and muscle atrophy can be rescued by inhibiting myogenin or myostatin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-1247
2211-1247
DOI:10.1016/j.celrep.2024.114587